San Diego, CA 6/23/2009 3:11:47 AM
STAAR Surgical Company (STAA) Analyzed at Small Cap Network
How much of a boost will STAAR Surgical Company (STAA) and the Epiphany injector system receive from government initiatives n biotech?
STAAR Surgical Company (STAA) and its FDA-approved Epiphany injector system are poised to benefit from a major Presidential biotech investment initiative over the next decade. A review and analysis of the stock is available at the Small Cap Network. The article also examines OSI Pharmaceuticals Inc. (OSIP) , and Akorn Inc. (AKRX).
Investors can receive complete access to all trading commentary and market trend analysis free by going to: www.smallcapnetwork.com/t/.
The biotech industry stands to benefit from $80 billion worth of investment from the White House over the next ten years. Small caps like OSI, STAAR Surgical, and Akorn are apt to see the biggest relative boost. The article's author looks at why these three stocks stand out among their peers.
Investors and traders are invited to subscribe to the free Small Cap Network Newsletter, which offers other trading ideas and insights at:www.smallcapnetwork.com/t/
About SmallCapNetwork
SmallCapNetwork.com's commentary and trading ideas are based on a combination of fundamental analysis, company news and events, and technical analysis. This combination of several kinds of criteria allows the site's analysts to find the very best trading ideas, which is why the site is quickly becoming the premier web destination for those seeking superior returns.
The Small Cap Network is one of the web's leading small cap stock trading communities. Though large caps tend to receive the majority of media attention, small and micro cap stocks as well as penny stocks can often offer the most potential for investment gains. The Small Cap Network web site and free newsletter offer in-depth fundamental research and technical trading recommendations on select companies within the global equity markets, including small cap stocks, micro cap stocks, bulletin board stocks, and actively traded penny stocks.
Forward-Looking Statement: This press release may include or imply "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
SmallCapNetwork.com is not a registered investment advisers or broker/dealer. SmallCapNetwork.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for many of their securities, investing in such securities is highly speculative and carries a high degree of risk.
Contact Information:
Small Cap Network
4653 Carmel Mtn. Rd Suite 308 #402
San Diego, CA 92130
Email: editor@smallcapnetwork.com
Source: Small Cap Networkhttp://community.smallcapnetwork.com/Pharmaceutical-Industry-to-Spend-80-Billion-Over-the-Next-Decade/s/article/view/p/mid/1/id/115/
